News
March 4th 2009
License Agreement with Cryonix
In 2008 SymbioTec has signed an exclusive license agreement for the drug development of ONCOHIST in the Russian Federation and Ukraine with Cryonix St. Petersburg.
The investigational trial with 120 AML patients in several clinics of Moscow and St. Petersburg is under preparation. The planned treatment schedule consists of a combination treatment with standard chemotherapy.
News Archive
November 2009: Phase IIB Clinical Trial ARAHIST-09 In November 2009 the open ...November 17th 2009: SymbioTec Wins Contest SymbioTec was elected ...
March 4th 2009: License Agreement with Cryonics In 2008 SymbioTec has signed ...
November 7th 2008: Orphan Drug status in the USA SymbioTec was granted ...
January 11th 2008: Orphan Drug status for SymbioTec On December 20th 2007 the ...
Downloads
365 Landmarks in the Land of Ideas (PDF) (556 KB)Press Release March 2009 (PDF) (112.1 KB)
Abstract ASH Meeting Dec 2007 (PDF) (12.3 KB)
Poster Freiburg Sep 2007 (PDF) (9.3 KB)
Press Release Feb 2005 (PDF) (9.5 KB)